Certified French language Translation of JUDGMENT AND REASONS rendered on 16-FEB-2015 by The Honourable Mr. Justice Barnes filed on 31-AUG-2016 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of JUDGMENT AND REASONS entered in J. & O. Book, volume 1311 page(s) 98 - 98 and copy placed on file.

Acknowledgment of Receipt received from all parties (by email) with respect to doc 65 placed on file on 18-FEB-2015

Reasons for Judgment and Judgment dated 16-FEB-2015 rendered by The Honourable Mr. Justice Barnes Matter considered with personal appearance The Court's decision is with regard to Directions of the Court dated 27-JAN-2015 Result: dismissed THIS COURT'S JUDGMENT is that Janssen's application is dismissed. The issue of costs will be addressed by the parties upon release of the Court's Judgment in the related proceeding Janssen Inc. v Teva Canada Limited,et al docket T-2194-12. Filed on 16-FEB-2015 copies sent to parties Interlocutory Decision Certificate of Judgment entered in J. & O. Book, volume 1258 page(s) 226 - 227

Confirmation of successful transmission by fax on behalf of all parties with regard to the Direcction dated January 27, 2015. placed on file on 27-JAN-2015

Written directions received from the Court: The Honourable Mr. Justice Barnes dated 27-JAN-2015 directing that Upon reviewing Mr. Moore's letter of January 23, 2015 concerning the release of unredacted Reasons in this proceeding, the Court directs that its Reasons will be released on Friday, January 30th, 2015 unless in the meantime any other party objects in writing by 4 pm on Thursday, January 29th. placed on file on 27-JAN-2015 Confirmed in writing to the party(ies)

Letter from Applicant dated 23-JAN-2015 in response to the oral Direction dated January 14, 2015...we are withdrawing our request to have portions of the decision redacted. (scanned to presiding Judge) received on 26-JAN-2015

Copy of Abstract of Hearing re: Case Management Conference concerning redactions and costs; dated 14-JAN-2015 placed on file on 14-JAN-2015 Original placed on Court File No. T-2194-12

Oral directions received from the Court: The Honourable Mr. Justice Barnes dated 09-JAN-2015 directing that "A Case Management Conference will take place on Wednesday, January 14, 2015 at 10:00 a.m. for an hour in duration. Parties are to attend the Ottawa Registry"; placed on file on 09-JAN-2015 Confirmed in writing to the party(ies)

Letter from Respondent Teva dated 02-JAN-2015 inquiring whether the Court still intends to arrange a conference call or if the written cost submissions should simply be filed in accordance with the Federal Courts Rules. (scanned to presiding Judge) received on 02-JAN-2015

Acknowledgment of Receipt received from Respondent Patentee and Applicant and Respondent Licensee and Sub Licensor with respect to Direction issued 9-DEC-2014 (Barnes, J.) placed on file on 09-DEC-2014

Acknowledgment of Receipt received from Teva and Minister with respect to Direction issued 9-DEC-2014 placed on file on 09-DEC-2014

Written directions received from the Court: The Honourable Mr. Justice Barnes dated 09-DEC-2014 directing that "The Court will deal with the issues of redactions to the decision in this proceeding in conjunction with the issue of costs and any proposed redactions to the pending decision in Janssen Inc. v Teva Canada Limited, et al., Docket T-2194-12. A conference call will be arranged by the Court to discuss these matters as soon as it is feasible." placed on file on 09-DEC-2014 Confirmed in writing to the party(ies)

Letter from Respondent, Teva Canada Limited (Teva") dated 02-DEC-2014 in response to the Applicant's submissions. (Scanned and Email to the Court) received on 02-DEC-2014

Letter from Respondent Patentee United States of America dated 01-DEC-2014 further to the Direction of the Court (Barnes, J.) issued Novembe 27, 2014. (scanned and sent to presiding Judge by email) received on 01-DEC-2014

Letter from the Applicant and Respondent Licensee and Sub-Licensee dated 01-DEC-2014 in response to the Direction of the Court (Barnes, J.) dated November 27/14 (scanned to the Court) received on 01-DEC-2014

Acknowledgment of Receipt received from all parties with respect to Direction and CONFIDENTIAL Judgment and Reasons 27-NOV-2014 placed on file on 28-NOV-2014

Reasons for Judgment and Judgment (CONFIDENTIAL) dated 27-NOV-2014 rendered by The Honourable Mr. Justice Barnes Matter considered with personal appearance The Court's decision is with regard to Judicial Review (s.18) Result: CONFIDENTIAL Filed on 27-NOV-2014 copies sent to parties Final Decision Certificate of Judgment entered in J. & O. Book, volume 1250 page(s) 143 - 143

Written directions received from the Court: The Honourable Mr. Justice Barnes dated 27-NOV-2014 directing that "Upon reviewing the redactions proposed by Janssen Inc. and the oppositioin to those redactions made by Teva Canada Limited, the Court directs that Janssen Inc. justify its position in writing by no later than noon on Monday December 1, 2014. Teva Canada Limited will have two days to respond in writing. Neither submission is to exceed 3 pages. The Confidential Judgment and Reasons will be filed forthwith under seal." placed on file on 27-NOV-2014 Confirmed in writing to the party(ies)

Letter from Respondent Teva dated 26-NOV-2014 further to the Applicant's letter dated November 14, 2014 and to the Respondent Patentee's letter dated November 26, 2014, proposing redactions to the Court's draft decision... received on 26-NOV-2014

Letter from Applicant (Janssen Inc) dated 27-NOV-2014 in response to Teva's letter dated November 26, 2014, whereby Teva disagreed with the redactions proposed by Janssen, Millennium and the Respondent Patentee to the draft decision in T-2195-12...In view of the above, Janssen and Millennium maintain that its proposed redactions (as set out in its' letter dated Nov. 14, 2014) are proper and necessary in view of the Confidentiality Order in this proceeding. (Scanned to hearing Judge) received on 27-NOV-2014

Letter from Respondent/Patentee United States of America dated 26-NOV-2014 further to Justice Barnes' directions dated November 5 and 21, 2014 concerning proposed redactions, if any, to his draft Decision in this matter. The Respondent Patentee has reviewed the draft Decision and, in accordance with the Confidentiality Order, requests that the portions of the draft Decision identified in the letter to the Court dated November 14, 2014 from counsel to the Applicants be expurgated. The Respondent Patentee does not require that any additional paragraphs be expurgated. received on 26-NOV-2014

Acknowledgment of Receipt received from Respondent Minister with respect to Direction issued 21-NOV-2014 placed on file on 25-NOV-2014

Acknowledgment of Receipt received from Respondent Teva with respect to Direction: 21-NOV-2014 placed on file on 21-NOV-2014

Acknowledgment of Receipt received from Respondent Patentee with respect to Direction: 21-NOV-2014 placed on file on 21-NOV-2014

Acknowledgment of Receipt received from Applicant Janssen and Respondent Licensee and Sub-Licensor Millennium with respect to Direction : 21-NOV-2014 placed on file on 21-NOV-2014

Written directions received from the Court: The Honourable Mr. Justice Barnes dated 21-NOV-2014 directing that "The Court has received a request on November 18, 2014 from counsel for the Respondent Patentee UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES to make submissions concerning proposed redactions, if any, to my draft decision. Counsel will have until Wednesday, Nov 26 at noon and the Court will consider those submissions." placed on file on 21-NOV-2014 Confirmed in writing to the party(ies)

Letter from Applicant dated 14-NOV-2014 addressed to the attention of the Honourable Mr. Justice Barnes and in response to the Court's Direction of November 5, 2014 providing submissions concerning proposed redactions to the draft decision in this matter. received on 14-NOV-2014

Draft Decision rendered by the Honourable Mr. Justice Barnes received on 05-NOV-2014

Letter from Respondent dated 10-NOV-2014 "We are solicitors for Teva Canada Limited ("Teva"), in the above-refereced proceeding. This is in response to the Direction of Justice Barnes Dated November 5, 2014. Teva has no redactions to propose to the draft Reasons for Judgment. Please correct the spelling of the name of "Jeffrey Warnock" that appears on the list of counsel on the last page." received on 10-NOV-2014

Written directions received from the Court: The Honourable Mr. Justice Barnes dated 05-NOV-2014 directing that "Each party shall have until Friday November 14, 2014 at noon to make submissions concerning proposed redactions, if any, to the attached draft decision before it is releases publicly." ( the Draft Decision attached was sent to the parties) placed on file on 05-NOV-2014 Confirmed in writing to the party(ies)

Transcript of hearing held at Ottawa on 11-SEP-2014 received on 29-SEP-2014 Sent directly to presiding Judge 274 pages (including covering pages).

Request received from the Court for Transcript of Hearing which took place from 08-SEP-2014 to 12-SEP-2014; sent to ASAP Reporting Services Inc. via e-mail; placed on file on 16-SEP-2014

Letter sent by Registry on 28-AUG-2014 to ASAP Reporting Services Inc. requesting the services of a court reporter for the hearing slated for 08-SEP-2014 to 12-SEP-2014; Copy placed on file.

Ottawa 11-SEP-2014 BEFORE The Honourable Mr. Justice Barnes Language: E Before the Court: Judicial Review Result of Hearing: Matter reserved held in Court Senior Usher: Brian Cooper Duration per day: 11-SEP-2014 from 09:35 to 17:00 Courtroom : Competition Tribunal, Room 610 - Ottawa Court Registrar: Anil Kamal 12-SEP-2014 from 09:07 to 12:12 Courtroom : Competition Tribunal, Room 610 - Ottawa Court Registrar: Anil Kamal Total Duration: 1d3h5min Appearances: Jamie Mills, Chantal Saunders, Beverly Moore, and Ryan Steeves (613) 369-4782 representing Applicant David Aitken, Bryan Norrie, and Jeffrey Warnock (613) 903-5099 representing Respondent, Teva Canada Limited Court Reporter: Suzanne Hubbard (613) 564-2727 11-SEP-2014 Nancy Grindley (613) 564-2727 12-SEP-2014 Transcript requested Comments: DARS Z0005108 was used; Minutes of Hearing entered in Vol. 913 page(s) 32 - 49 Abstract of Hearing placed on file

Supplemental Book of Authorities consisting of 1 volume(s) on behalf of Respondent, Teva Canada Limited, received on 11-SEP-2014 Sent directly to Presiding Judge

Compendium consisting of 2 volume(s) on behalf of Respondent, Teva Canada Limited, received on 11-SEP-2014 Sent directly to Presiding Judge

'146 Patent consisting of 1 volume(s) on behalf of Applicant received on 11-SEP-2014 Sent directly to Presiding Judge

Confidential Daybook consisting of 3 volume(s) on behalf of Applicant received on 11-SEP-2014 Sent directly to Presiding Judge

Letter from Applicant dated 05-SEP-2014 advising that the parties have discussed the hearing of both matters (T-2194-12 and T-2195-12) and provide the Court with a proposed schedule for the hearing and other information requested by the Court. - scanned to Hearings Judge - received on 05-SEP-2014

Acknowledgment of Receipt received from all parties except Minister of Health with respect to Doc. 63 placed on file on 26-AUG-2014

Amendment to the Confidentiality Order dated 25-AUG-2014 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent dated 11-AUG-2014 Result: paragraph 1(g) of the Order is amended to remove the members and professional support staff of Osler, Hoskin and Harcourt LLP, and to insert the members and professionsl support staff of Aitken Klee LLP, as "Counsel for Teva" Filed on 25-AUG-2014 copies sent to parties entered in J. & O. Book, volume 1240 page(s) 491 - 492 Interlocutory Decision

Covering letter from Respondent, Teva Canada Limited dated 22-AUG-2014 concerning Doc. Nos. 61 62 placed on file on 22-AUG-2014

Solicitor's certificate of service on behalf of Jeffrey Warnock confirming service of Public (redacted) version of the Respondent's (TEVA CANADA LIMITED) Application Record (Doc 61) upon Applicant , Respondent Licensee and Sub-Licensor by hand on 22-AUG-2014 confirming service same upon Respondent Minister of Health by email with consent on 22-AUG-2014 confirming service same upon Respondent Patentee (US Dept. of Health) by hand on 22-AUG-2014 filed on 22-AUG-2014

Public (Redacted) version of the Respondent's (TEVA CANADA LIMITED) Application Record filed on 22-AUG-2014

Communication to the Court from the Registry dated 21-AUG-2014 re: request on behalf of Respondent, Teva, on consent, for an amendment to the Confidentiality Order

Letter from Janssen Inc. and Millennium Pharmaceuticals Inc. dated 18-AUG-2014 Further to the teleconference on Aug. 5/14 Janssen and Millennium will not be bringing a motion for recusal (scanned to the Court) received on 18-AUG-2014

Covering letter from the Respondent (Teva Canada Ltd.) dated 11-AUG-2014 concerning Doc. No. 60 and Draft Amendment placed on file on 11-AUG-2014

Draft Amendment to the Confidentiality Order concerning Order of Prothonotary Tabib, dated April 25, 2013. received on 11-AUG-2014

Consent on behalf of all parties to the proposed amendment to the Confidentiality Order of Prothonotary Tabib, dated April 25, 2013. filed on 11-AUG-2014

Ottawa 05-AUG-2014 BEFORE The Honourable Mr. Justice Barnes Language: E Before the Court: Meeting to discuss the Applicant's July 10, 2014 letter, and the hearing scheduled for September 8, 2014. (This matter and T-2194-12) Result of Hearing: The Court advises the Applicant that a request for recusal would need to be made by way of a motion. The Applicant is asked to advise as soon as possible if this is their intent. Parties are asked to work on a document outlining the points on which the parties agree, for use by the Court at the hearing. held by way of Conference Call Duration per day: 05-AUG-2014 from 10:00 to 10:12 Courtroom : Ottawa Registry Office Court Registrar: Danielle Lanteigne Total Duration: 12min Appearances: Mr. Jamie Mills, Ms. Chantal Saunders 613-369-4782 representing Applicant Mr. Marcus Klee, Mr. Bryan Norrie 613-903-5100 representing Respondent Mr. Kiernan Murphy, Mr. Christopher Van Barr 613-786-0273 representing Respondent Patentee (USDOJ) Comments: Full minutes of hearing are on related file T-2194-12 Minutes of Hearing entered in Vol. 910 page(s) 474 - 475 Abstract of Hearing placed on file

Memorandum to file from D. Lanteigne, Ottawa dated 05-AUG-2014 the Court has Directed that the Digital Audio Recording System (DARS) NOT be used for this morning's meeting by teleconference. placed on file.

Memorandum to file from Victoria Bell - Registry Officer Ottawa dated 24-JUL-2014 I spoke with counsel for Teva (J. Warnock) this afternoon with regard to his letter of July 21, 2014 and the letter received in response on July 23, 2014. Counsel indicated that the parties are discussing the matter and that if intervention by the Court is required that they will write and request such. placed on file.

Letter from Applicant dated 23-JUL-2014 in response to letter of the Respondent dated 21-JUL-2014 concerning confidential Application Record. received on 24-JUL-2014

Acknowledgment of Receipt received from Applicant with respect to Direction 23-JUL-2014 placed on file on 23-JUL-2014

Oral directions received from the Court: The Honourable Mr. Justice Barnes dated 23-JUL-2014 directing that a teleconference will be held on 5-AUG-2014 at 10 a.m. Ottawa time. Parties are to remain in their respective offices. placed on file on 23-JUL-2014 Confirmed in writing to the party(ies)

Letter from Respondent TEVA CANADA LIMITED dated 21-JUL-2014 enclosing Confidential copies of the Application Record, Book of Authorities and Solicitor's Certificcate of Service; 'since counsel for the Applicant has marked their record confidential, Teva has only included a confidential version. We would request further specific instructions from the Applicant as to which portions of their Application Record are confidential before we can file a public version.' received on 21-JUL-2014

Copy of letter from TEVA CANADA LIMITED to all parties re: confidential application record and book of authorities placed on file on 21-JUL-2014

Solicitor's certificate of service on behalf of Jeffrey Warnock confirming service of Confidential Application Record and Book of Authorities upon Applicant/Resp Licensee/Resp.Patentee (by hand); Res.Min of Health(by email) by personal service and email on 21-JUL-2014 filed on 21-JUL-2014

Book of Authorities consisting of 1 volume(s) on behalf of Respondent TEVA CANADA LIMITED received on 21-JUL-2014

Sealed envelope pursuant to Order of the Court of 25-APR-2013 on behalf of Respondent TEVA CANADA LIMITED purporting to contain Application Record Filed on 21-JUL-2014

Oral directions received from the Court: The Honourable Mr. Justice Barnes dated 10-JUN-2014 directing that A CASE MANAGEMENT CONFERENCE SHALL BE SCHEDULED FOR 25-JUN-2014 AT 17:00 EST FOR APPROXIMATELY ONE HOUR VIA TELECONFERENCE. (COMMUNICATED TO THE PARTIES VIA ELECTRONIC MAIL) placed on file on 10-JUN-2014

Letter from Applicant dated 10-JUL-2014 "... Based on the fact that a case management conference was scheduled with Justice Barnes, we assume that Justice Barnes is the Application Judge currently assigned to hear this matter and T-2194-12... Given that the Court's normal procedure was breached by providing this information after Janssen and Millenium filed their Application Record... but before Teva Canada Limited filed its Memorandum, we assume that a new Application Judge will be assigned to overcome any prejudice to Jansse and Millenium. Please confirm that our understanding in this regard is correct..." - scanned to the Judicial Administrator - received on 11-JUL-2014

Oral directions received from the Court: The Honourable Mr. Justice Barnes dated 25-JUN-2014 directing that THE CASE MANAGEMENT CONFERENCE ORIGINALLY SCHEDULED FOR 25-JUN-2014 AT 17:00 EST VIA TELEPHONE SHALL BE ADJOURNED TO A DATE AND TIME TO BE SET BY THE COURT. (COMMUNICATED TO THE PARTIES VIA ELECTRONIC MAIL) placed on file on 25-JUN-2014

Communication to the Court from the Registry dated 25-JUN-2014 re: Letter dated 25-JUN-2014 from Janssen Inc. requesting CMC for 25-JUN-2014 at 5PM be postponed sent to presiding Judge.

Letter from Applicant dated 25-JUN-2014 "...Further to the case management conference to discuss the status of the proceeding...on Wednesday, June 25, 2014 at 5PM...Jansen and Millennium respectfully request that this case management conference be postponed..." cc to all parties received on 25-JUN-2014

Covering letter from Applicant dated 21-MAY-2014 concerning Doc. Nos. 56 57 placed on file on 21-MAY-2014

Solicitor's certificate of service on behalf of Chantal Saunders confirming service of doc. 56 and book of authorities upon all parties by process server on 21-MAY-2014 filed on 21-MAY-2014

Book of Authorities consisting of 2 volume(s) on behalf of applicant and Millennium Pharmaceuticals Inc. received on 21-MAY-2014

Application Record of the applicant and Millennium Pharmaceuticals Inc. consisting of 23 volumes including confidential volumes 3,9,10,12,16,17,20 and 23 Three copies filed. Judge's copy stored in Ottawa filed on 21-MAY-2014

Notice of Change of Address on behalf of Aitken Klee LLP filed on 29-APR-2014

Acknowledgment of Receipt received from all parties (by e-mail)_ with respect to the Order of the Court dated 19-DEC-2013 placed on file on 20-DEC-2013

Order dated 19-DEC-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent dated 17-DEC-2013 re: requesting extensions of time Result: granted "1. Cross-examinations on affidavits shall be completed by March 21, 2014. 2. The Applicant and Respondent Lincensee's application record shall be served and filed by May 21, 2014. 3. The Respondent's application record shall be served and filed by July 21, 2014." Filed on 19-DEC-2013 copies sent to parties entered in J. & O. Book, volume 1215 page(s) 30 - 31 Interlocutory Decision

Communication to the Court from the Registry dated 18-DEC-2013 re: letter from the respondents received 18-DEC-2013

Letter from Respondent dated 17-DEC-2013 requesting extensions of time to the schedule for the completion of the cross-examinations and serving and filing of the application records on consent of the Applicant. received on 18-DEC-2013

Acknowledgment of Receipt received from all parties with respect to Order (time and place)(Doc. No. 53). placed on file on 23-OCT-2013

Order (time and place) dated 23-OCT-2013 rendered by Acting Chief Justice S Noël and signed by Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Ottawa on 08-SEP-2014 to begin at 09:30 duration: 2d 3h language: E Filed on 23-OCT-2013 cc's sent to parties entered in J. & O. Book, volume 1208 page(s) 183 - 184 Transmittal letters placed on file

Letter from Respondent dated 23-OCT-2013 further to the discussion with the Registry regarding dates for the hearing of the application in T-2195-12. The parties have agreed that the week of September 8-12 will be sufficient for the hearing of both T-2194-12 and T-2195-12 if heard together. Counsel for all parties in T-2195-12 have previously confirmed availability for a hearing the week of September 8-12, 2014. received on 23-OCT-2013

Copy of letter on behalf of Applicant enclosing Requisition for Hearing and outlining remaining issues for both files T-2194-12 and T-2195-12 dated 22-OCT-2013 placed on file on 22-OCT-2013 Original placed on Court File No. IMM-2194-12

Amended Solicitor's certificate of service on behalf of Chantal Saunders confirming service of doc. 50 Requisition for hearing upon the Respondent, Teva Canada Limited by 07-oct-2013 on 07-OCT-2013 confirming service doc. 50 upon The Minister of health and the Respondent Patentee, the USA by telecopier on 04-OCT-2013 filed on 04-OCT-2013

Communication to the Court from the Registry dated 07-OCT-2013 re: File sent to TrialJA to set down hearing date

Letter from counsel for the Applicant and Respondent Licensee and Sub-Licensor dated 04-OCT-2013 attaching a cheque to cover the filing fee of the Requisition for Hearing which will be served and filed later in the afternoon. received on 04-OCT-2013

Covering letter from Chantal Saunders, counsel for Applicant and Respondent Licensee/Sub-Licensor dated 04-OCT-2013 concerning Doc. Nos. 50 51 placed on file on 04-OCT-2013

Solicitor's certificate of service on behalf of Chantal Saunders confirming service of the Requisition for Hearing upon the Respondents, Teva Canada Ltd. and the Minister of Health by telecopier on 04-OCT-2013 confirming service the Requisition for Hearing upon the Respondent Patentee, the United States of America by telecopier on 04-OCT-2013 filed on 04-OCT-2013

Requisition for hearing - Application from Applicant filed on 04-OCT-2013 Tariff Application or appeal - $50.00

Letter from Chantal Saunders, counsel for Janssen Inc. & Millennium Pharmaceuticals dated 04-OCT-2013 Further to the Order dated March 5, 2013, they are advising that Janssen and Millennium will not be bringing a motion pursuant to Rule 312 of the FCR. received on 04-OCT-2013

****** CANCELLED ****** Covering letter from . dated 23-SEP-2013 concerning . placed on file on 23-SEP-2013

Solicitor's certificate of service on behalf of Daniel Hynes (Respondent, Teva Canada Limited) confirming service of documents 46, 47, 48 upon Applicant, Respondent Licensee/Sub-Licensor and Respondent/Patentee by personal service on 20-SEP-2013 confirming service documents 46, 47, 48 upon Respondent, The Minster of Health by Electronic Mail on 20-SEP-2013 filed on 23-SEP-2013

****** CANCELLED ****** Affidavit of . sworn on 20-SEP-2013 on behalf of . . filed on 23-SEP-2013

****** CANCELLED ****** Affidavit of . sworn on 19-SEP-2013 on behalf of . . filed on 23-SEP-2013

****** CANCELLED ****** Affidavit of . sworn on 19-SEP-2013 on behalf of . . filed on 23-SEP-2013

Ottawa 06-SEP-2013 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss the issues raised in the parties' correspondence dated August 13 and 16, 2013 Result of Hearing: The Court encouraged the parties to resolve the issues amongst themselves held in chambers by way of Conference Call Duration per day: 06-SEP-2013 from 11:00 to 11:20 Courtroom : Judge's Chambers - Ottawa Court Registrar: Alison Dickenson Total Duration: 20min Appearances: Beverley Moore and Ryan Steeves (613) 369-4784 representing Applicant/ Respondent Licensee and Sub-Licensor Marcus Klee and Jonathan Giraldi (613) 695-5858 ext. 222 representing Respondent Teva Canada Limited Kiernan Murphy (613) 786-0273 representing Respondent Patentee * no one appearing * representing Respondent Minister of Health Comments: No Direction will issue. Minutes of Hearing entered in Vol. 886 page(s) 41 - 43 Abstract of Hearing placed on file

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to the Direction of the Court dated 30-AUG-2013 placed on file on 03-SEP-2013

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 30-AUG-2013 directing that a case management telephone conference will be held at 11am on September 6, 2013. placed on file on 30-AUG-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 29-AUG-2013 re: letter from the Respondent, Teva, dated 29-AUG-2013

Letter from Respondent dated 29-AUG-2013 advising of the mutual dates of availability of counsel for a CMC received on 29-AUG-2013

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to the Direction of the Court dated 27-AUG-2013 placed on file on 28-AUG-2013

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 27-AUG-2013 directing that "Counsel for Teva is requested to provide both counsels' availability for a case management telephone coference if Teva is of the view that one is still necessary." placed on file on 27-AUG-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 20-AUG-2013 re: letters from the Respondent and Applicant dated August 13, 2013 and August 16, 2013 respectively

Letter from Applicant dated 16-AUG-2013 in response to the letter from counsel for Teva dated August 13, 2013 with attached jurisprudence received on 16-AUG-2013

Letter from the Defendant, Teva Canada Limited dated 13-AUG-2013 requesting a case management conference to discuss unredacted reports requested of the Plaintiff, and attaching case law. received on 13-AUG-2013

Covering letter from Applicant dated 21-JUN-2013 concerning Doc. No. 45 placed on file on 21-JUN-2013

Solicitor's certificate of service on behalf of Chantal Saunders confirming service of the Applicant's Rule 306 evidence upon all parties by personal service on 21-JUN-2013 filed on 21-JUN-2013

Acknowledgment of Receipt received from all parties (by fax) with respect to doc 44 placed on file on 23-MAY-2013

Order dated 22-MAY-2013 rendered by The Honourable Mr. Justice Boivin Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 38 Result: THIS COURT ORDERS that the Commissioner of patents, pursuant to section 52 of the Patent Act, shall vary all entries in the records of the Canadian Patent Office with respect to the inventorship of Canadian Patent No. 2,435,146 by adding Dr. Valentino J. Stella and Ms. Wanda Waugh as inventors. Filed on 23-MAY-2013 copies sent to parties entered in J. & O. Book, volume 1193 page(s) 423 - 425 Interlocutory Decision

Communication to the Court from the Registry dated 13-MAY-2013 re: Motion doc. 38 on consent (in writing) with proof of service as requested by the Court (forwarded to duty Judge at the request of the Court (Tabib, P.) )

Communication to the Court from the Registry dated 06-MAY-2013 re: Motion Doc. 38 on consent (in writing)

Acknowledgment of Receipt received from all parties by email with respect to Doc.37 and ID:81 placed on file on 02-MAY-2013

Covering letter from Respondent Licensee & Sub-Licensor, Millennium Pharmaceuticals, Inc. dated 01-MAY-2013 concerning documents 42, 43 and Authorities placed on file on 01-MAY-2013

Solicitor's certificate of service on behalf of Chantal Saunders confirming service of document 42 and Authorities upon Respondent, Minister of Health by personal service on 30-APR-2013 confirming service document 42 and Authorities upon Applicant Janssen Inc., by personal service on 30-APR-2013 confirming service document 42 and Authorities upon Respondent, Patentee, the United States of America by personal service on 30-APR-2013 confirming service document 42 and Authorities upon Respondent, Teva Canada Limited by personal service on 01-MAY-2013 confirming service document 42 and Authorities upon Respondent Respondent Licensee & Sub-Licensor, Millennium Pharmaceuticals by courier on 01-MAY-2013 filed on 01-MAY-2013

Book of Authorities consisting of 1 volume(s) on behalf of Respondent Licensee & Sub-Licensor received on 01-MAY-2013

Motion Record containing the following original document(s): 38 39 40 41 Number of copies received: 3 on behalf of Respondent Licensee & Sub-Licensor filed on 01-MAY-2013

Written Representations contained within a Motion Record on behalf of Respondent Licensee & Sub-Licensor concerning Motion Doc. No. 38 filed on 01-MAY-2013

Consent on behalf of Applicant Respondent Licensee & Sub-Licensor Respondent Patentee, united states of America to Motion Document 38 filed on 01-MAY-2013

Affidavit of Cindy Sue Potter sworn on 24-APR-2013 contained within a Motion Record on behalf of Respondent Licensee & Sub-Licensor in support of Motion Doc. No. 38 with Exhibits A-H filed on 01-MAY-2013

Draft Order concerning Motion Doc. No. 38 received on 01-MAY-2013

Notice of Motion contained within a Motion Record on behalf of Respondent Licensee & Sub-Licensor in writing to be placed before the Court in Ottawa for for the Commissioner of Patents, to vary all entries in the records of the Patent Office with respect to the inventorship of Canadian Patent No. 2,435,146 by adding Valentino J. Stello and Wanda Waugh as inventors; and such futher and other order... filed on 01-MAY-2013 Draft Order\\Judgment received.

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 25-APR-2013 directing that "The parties' attention is drawn to changes made to their draft order at paragraphs 5, 6(b), 18 and 19." placed on file on 29-APR-2013 Confirmed in writing to the party(ies)

CONFIDENTIALITY ORDER dated 25-APR-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion in writing Doc. No. 28 Result: granted Filed on 25-APR-2013 copies sent to parties entered in J. & O. Book, volume 1191 page(s) 208 - 217 Interlocutory Decision

Solicitor's certificate of service on behalf of Marcus Klee confirming service of doc. 35 upon all parties by telecopier on 23-APR-2013 filed on 24-APR-2013

Notice of change of solicitor on behalf of Teva Canada Ltd. filed on 24-APR-2013

Communication to the Court from the Registry dated 23-APR-2013 re: Motion in writing Doc. 28

Solicitor's certificate of service on behalf of Chantal Saunders confirming service of Motion Record and Book of Authorities upon the Respondents Teva Canada Limited and USA by process server on 22-APR-2013 confirming service Motion Record and Book of Authorities upon the Respondents Minister of Health and Millennium Pharmaceuticals Inc. by hand on 22-APR-2013 filed on 22-APR-2013

Book of Authorities (Motion for a Protective and Confidentiality Order) consisting of 1 volume(s) on behalf of Applicant received on 22-APR-2013

Motion Record containing the following original document(s): 28 29 30 31 32 Number of copies received: 3 on behalf of Applicant filed on 22-APR-2013

Written Representations contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 28 filed on 22-APR-2013

Consent on behalf of counsel for all parties to Draft Order attached as Schedule "A" filed on 22-APR-2013

Affidavit of Lisa Mackie sworn on 18-APR-2013 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 28 filed on 22-APR-2013

Affidavit of James E. Brodie sworn on 17-APR-2013 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 28 filed on 22-APR-2013

Draft Confidentiality Order concerning Motion Doc. No. 28 received on 22-APR-2013

Notice of Motion contained within a Motion Record on behalf of Applicant in writing to be placed before the Court in Ottawa for an Order for the maintenance of the confidentiality of certain confidential documents and information in the proceeding, in the form attached as "Schedule A" filed on 22-APR-2013 Draft Order\\Judgment received.

Covering letter from Borden Ladner Gervais dated 22-APR-2013 concerning ... Madam Prothonotary Tabib ... Applicant's Motion Record and Book of Authorities, together with proof of service ... placed on file on 22-APR-2013

Solicitor's certificate of service on behalf of Melissa Binns confirming service of Doc.26 upon all parties by telecopier on 28-MAR-2013 filed on 02-APR-2013

Notice of appearance on behalf of Respondent Patentee(USA Represented by the Secretary, Dept. of Health...) filed on 02-APR-2013

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 08-APR-2013 directing that Re: Notice of Appearance submitted by the Respondent Patentee on 2-APR-2013 "Accept for filing" placed on file on 08-APR-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 08-APR-2013 re: Notice of Appearance submitted by USA, Represented by the Secretary, Dept. of health and Human Services was received April 2, 2013. The document is out of time and required Directions of the CMJ.

Covering letter from Applicant dated 21-MAR-2013 concerning Certified copy of Patent No. CA 2,435,146 placed on file on 21-MAR-2013

Certified Copy of Original File relating to patent re: CA 2,435,146 received from Applicant on 21-MAR-2013 placed on file on this file

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 13-MAR-2013 directing that RE: Applicant's letter dated March 8, 2013 seeking an extension of time until April 22, 2013 for Janssen and Millennium to serve and file their motion materials for the Confidentiality Order and an extension until May 6, 2013 for the serving and filing of the Respondent's materials, if any "Extension granted as requested" placed on file on 13-MAR-2013 Confirmed in writing to the party(ies)

Letter from Applicant & Respondent Patentee/Sub-Licensor Millennium Pharmaceuticals Inc. dated 08-MAR-2013 further to their letter dated 25-FEB-2013 with respect to a proposed schedule for the filing of a Motion for a Confidentiality Order, and subsequent to discussions during the case management conference held on 5-MAR-2013; requesting an extension of time for the filing of the parties' Motion materials as follows: -the deadline for filing Janssen and Millennium's Motion materials be moved to 22-APR-2013; -the deadling for the filing of the Respondents' materials, if any, be moved to 6-MAY-2013... Counsel for Teva and Counsel for the Minister have indicated that they take no position with respect to proceeding in this fashion. (Letter scanned to the Court on 8-MAR-2013) received on 08-MAR-2013

Acknowledgment of Receipt received from all parties by email 6-MAR-13 with respect to Doc.25 placed on file on 06-MAR-2013

Order dated 05-MAR-2013 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1. The Applicant and Respondent Licensee's evidence shall be served no later than 21-JUN-13; 2. The Respondent's evidence shall be served no later than 21-SEP-13; 3. The Applicant and Respondent Licensee shall serve and file a requisition for hearing no later than 4-OCT-13; 4. The Applicant and Respondent Licensee will advise the parties and the Court whether a motion pursuant to R. 312 FCR is necessary by 4-OCT-13 and will provide availability for a case management conference prior to the filing of such motion. 5. Cross-examinations on affidavits shall be completed by 21-DEC-13; 6. Applicant and Respondent Licensee's application record served & filed by 21-FEB-2014.; 7. Respondent's application record served/filed by 31-MAR-2014 Filed on 06-MAR-2013 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1186 page(s) 101 - 102 Interlocutory Decision

Ottawa 05-MAR-2013 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss the parties submissions regarding the schedule dated February 25, 2013. Result of Hearing: The schedule was discussed and parties came to an agreement on all deadlines for further steps to be taken. An Order will issue shortly. Counsel for the Respondent Patentee, Mr. Malcolm Ruby (Gowlings/TOR) and his client, Mr. Jonathan Welch, were present for the first 5 minutes of the teleconference. The Court has indicated that they have not yet filed a Notice of Appearance, however the Court has taken note of their representations as to why they have not done so to date. held in chambers by way of Conference Call Duration per day: 05-MAR-2013 from 10:00 to 10:20 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 20min Appearances: Chantal Saunders 613-369-4783 representing Janssen Inc. and Millennium Marcus Klee and Bryan Norrie 613-787-1049 representing Teva Canada Ltd. Malcolm Ruby 416-319-6056 representing the Respondent Patentee Jonathan Welch 202-616-8147 representing Department of Justice of the United States Minutes of Hearing entered in Vol. 876 page(s) 271 - 274 Abstract of Hearing placed on file

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 28-FEB-2013 directing that "A case management telephone conference will be held at 10:00a.m. on March 5, 2013." placed on file on 28-FEB-2013 Confirmed in writing to the party(ies)

Letter from Applicant dated 26-FEB-2013 concerning the Motion documents filed on Feb 7/13 which contained an incorrect file number and advising what the correct filed number should have been. received on 26-FEB-2013

Communication to the Court from the Registry dated 26-FEB-2013 re: Applicant and Respondent's letters dated 25-FEB-2013

Letter from Respondent (Teva) dated 25-FEB-2013 "We are writing in accordance with the Order...dated February 11, 2013,... and further to Ms. Saunders' letter to the Court which was filed earlier today. As set out in Ms. Saunders' letter, the parties do not contemplate the filing of motions pursuant to Section 6(5) or 6(7)...The parties have agreed to a schedule for the filing of a Confidentiality Order, and expect to reach an agreement shortly regarding the form of a draft Confidentiality Order for filing. The parties have not been able to reach an agreement regarding the schedule...Teva submits that the application should be governed by the following schedule: (see letter for details) received on 25-FEB-2013

Letter from Applicant dated 25-FEB-2013 Submissions in compliance with the Court's Order dated February 11, 2013, re: 6(7)motion not contempletd; confidentiality Order is required, with a motion to be filed by March 11, 2013; 6(5) motion is not contemplated; the parties have been unable to reach an agreement with respect to the timetable; the Applicant and Respondent Licensee intend to bring a motion to amend the inventorship of the patent in issue; the Applicant and Respondent Licensee propose the following schedule: (see letter for details); availability for a case management conference: corporate parties are jointly available from12:30-1:30 on Feb. 26, 27 and March 1, or any time on March 4-6. received on 25-FEB-2013

Memorandum to file from Ann Murphy dated 26-FEB-2013 counsel for the Respondent Licensee has been advised that two of the documents filed on February 6, 2013 (docs 22, 23) contained an incorrect file number. Counsel will send a letter concerning this matter. The registry corrected the file number on the documents on Feb 6, 2013. placed on file.

Acknowledgment of Receipt received from all parties by email on Feb.12 with respect to Doc.24 placed on file on 12-FEB-2013

Communication to the Court from the Registry dated 05-FEB-2013 re: Communication (informal)advising the CMJ of receipt of a letter from Foreign Affairs (USA) with attached certificate confirming service of the Notice of Application, pursuant to ss. 9(5) of the State Immunity Act, to the appropriate authority of the Government of the USA. Madam Prothonotary Tabib has directed that these materials be accepted onto the Court record.

CERTIFICATE, pursuant to Susbsection 9(5) of the State Immunity Act, that the Notice of Application pertaining to this action was transmitted to the appropriate authority of the Government of the United States of America on January 28, 2013. received on 04-FEB-2013

Letter from Director of Criminal, Security and Diplomatic Law Division (Foreign Affairs) dated 28-JAN-2013 confirming that the law firm of Borden Ladner Gervais LLP, on December 20, 2012, requested service of the Notice of Application on the Government of the United States of America, in this action, pursuant to the State Immunity Act. (Certificate indicating that the document was transmitted to the Government of the USA on January 28, 2013) received on 04-FEB-2013

Order dated 11-FEB-2013 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 9 Result: dismissed ...2. The parties shall, no later than 14 days from the date of this Order, either jointly or seperately, file written submissions as to the following matters and issues: a) whether any motion pursuant to S.6(7) of the PM(NOC) Regs. is contemplated, and if so, a proposed schedule for filing parties' respective motion materials. b) whether any motion for a confidentiality Order is contemplated, and if so, a proposed schedule for filing parties' respective motion materials. c) whether any motion pursuant to S. 6(5)(a) or (B) of the PM(NOC) Regs. is contemplated, and if so, the timeframe for bringing such a motion. d) a proposed schedule for further steps to be taken including whether the parties have agreed to a partial or full reversal of the order of filing evidence, and if not, whether any motion to that effect is contemplated, together with, as the case may be, a proposed schedule for filing the parties' respective motion materials on such a motion. e) Both counsel's joint availabilities to participate in a case management telephone conference to discuss the proposals, issues or matters listed above. Filed on 11-FEB-2013 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1183 page(s) 426 - 431 Interlocutory Decision

Communication to the Court from the Registry dated 01-FEB-2013 re: Doc. No. 9

Ottawa 07-FEB-2013 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Continuation of the Motion Doc. No. 9 on behalf of Respondent, Teva Canada Limited, Result of Hearing: Matter dismissed held in Court Senior Usher: D. Cormier Duration per day: 07-FEB-2013 from 09:36 to 11:18 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Anil Kamal Total Duration: 1h42minà Appearances: Mr. James E. Mills (613) 369-4782 representing Respondent, Millenium Pharmaceuticals, Inc. Mr. Marcus Klee & Mr. Bryan Norrie (613) 235-7234 representing Respondent, Teva Canada Limited Minutes of Hearing entered in Vol. 875 page(s) 221 - 225 Abstract of Hearing placed on file

Book of Authorities consisting of 1 volume(s) on behalf of Respondent, Millennium Pharmaceuticals Inc., received on 06-FEB-2013 Sent directly to Presiding Judge

Covering letter from Respondent Licensee and Sub Licensor, Millennium Pharm. Inc. dated 06-FEB-2013 concerning Doc. Nos. 22 23 placed on file on 06-FEB-2013

Solicitor's certificate of service on behalf of Chantal Saunders confirming service of Document 22 and Book of Authorities upon Applicant Janssen Inc., by personal service on 06-FEB-2013 confirming service Document 22 and Book of Authorities upon Respondent, Teva Canada Limited by personal service on 06-FEB-2013 confirming service document 22 and Book of Authorities upon Respondent, Minister of Health by personal service on 06-FEB-2013 filed on 06-FEB-2013

Motion Record in response to Motion Doc. No. 9 containing the following original document(s): 20 21 Number of copies received: 3 on behalf of Respondent Licensee and Sub Licensor, Millennium Pharm. Inc. filed on 06-FEB-2013

Written Representations contained within a Motion Record on behalf of Respondent Licensee & Sub Licensor, Millennium Pharm. Inc. concerning Motion Doc. No. 9 filed on 06-FEB-2013

Affidavit of Ryan Steeves sworn on 06-FEB-2013 contained within a Motion Record on behalf of Respondent Licensee and Sub Licensor, Millennium Pharm. in opposition to Motion Doc. No. 9 with Exhibits A-H filed on 06-FEB-2013

****** ANNULÉ(E) ****** Directives verbales reçu(es) de la Cour: Mireille Tabib, protonotaire en date du 28-JAN-2013 "La conférence de gestion prévue pour le 29 janvier 2013 est ajournée au 30 janvier 2013 à 10h, par conférence téléphonique." placées au dossier le 28-JAN-2013 Confirmées par écrit à la(aux) partie(s)

Correction to General Sitting concerning Motion Doc. No. 9 Hearing added to General Sitting at Ottawa on 07-FEB-2013 at 09:30 duration: 1h Language: E Reason for correction: Letter dated 25-JAN-2013

Letter from Respondent Teva Canada Limited dated 25-JAN-2013 advising that the corporate parties are mutually available for the hearing of Teva's Motion (Doc. 9) to strike on 7-FEB-2013 (General Sittings). The Minister of Health will not be participating in the Motion. received on 25-JAN-2013

Acknowledgment of Receipt received from all parties (by EMAIL) with respect to the Order of the Court dated 9-JAN-2013 placed on file on 10-JAN-2013

Affidavit of service of Kevin Arbery sworn on 02-JAN-2013 on behalf of Applicant confirming service of the Notice of Application upon Respondent Patentee, United States of America represented by the Secretary, Department of Health and Human Services by by delivering a copy by hand on 02-JAN-2013 filed on 02-JAN-2013

Order dated 09-JAN-2013 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 09-JAN-2013 Result: "The Applicant, Janssen Inc., shall serve the Notice of Application on the Respondent Patentee, United States of America, represented by the Secretary, Department of Health and Human Services, by January 2, 2013." Filed on 09-JAN-2013 copies sent to parties entered in J. & O. Book, volume 1180 page(s) 76 - 77 Interlocutory Decision

Consent on behalf of all parties to the Draft Order attached as Schedule "A" (the parties request for an extension of time to serve the Respondent patentee with Notice of Application) filed on 09-JAN-2013

Letter from Applicant dated 09-JAN-2013 requesting an extension of time to January 2, 2013 to serve the Respondent patentee with the Notice of Application and requesting that the Court dispense with the need for a motion record. - scanned to Tabib, P. - received on 09-JAN-2013

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 19-DEC-2012 directing that "It is the Court's preferred practice that the parties requesting a case management telephone conference communicate with their opponent and provide the Court with both counsel's mutual dates of availability for a case conference. That practice also ensures that where the perceived need for a case conference arises from a miscommunication between the parties rather than a genuine difference of opinion, the matter be resolved more expeditiously between the parties themselves. The Court will not fix a case conference herein until counsel, having communicated between themselves, advise that there remains a need for a case conference and provide their mutual dates of availability." placed on file on 19-DEC-2012 Confirmed in writing to the party(ies)

Letter from Applicant dated 19-DEC-2012 enclosing the Notice of Appearance (Doc.15) with proof of service (Doc.16) Please note we have not yet served the United States of America as it has yet to accept service of the Notice of Application and file its Notice of Appearance in this matter. An extension of time has been sought by letter dated Dec. 14 and we are awaiting directions. received on 19-DEC-2012

Affidavit of service of Cindy Sue Potter sworn on 18-DEC-2012 on behalf of Applicant confirming service of doc.15 upon the applicant, respondent and the Minister by by hand (applicant) and by fax (Teva, Minister) **NOTE: USA not served on 18-DEC-2012 filed on 19-DEC-2012

Notice of appearance on behalf of the Respondent Licensee and Sub-Licensor, Millennium Pharmaceuticals Inc. filed on 19-DEC-2012

Communication to the Court from the Registry dated 18-DEC-2012 re: Letters submitted by counsel on December 14, 17 and 18; Teva's motion to strike the respondent, Millenium from this application/Doc.9, to be set down

Letter from Applicant(Janssen Inc. & Respondent Licensee, Millenium) dated 18-DEC-2012 further to the letter dated December 17, 2012, from counsel for Teva... we respectfully request that the Court grant the 2 requested extensions of time so thatJanssen can move to effect service on the Respondent Patentee and the delay in the case is minimized to the greatest extent possible. If necessary, we are generally available for a case management conference December 19, the morning of Dec. 20 before 11am, and December 21, 2012. received on 18-DEC-2012

Letter from Respondent(Teva) dated 17-DEC-2012 in response to the letter dated December 14, 2012 from counsel for the Applicant, requesting a direction granting an extension of time to serve the "USA" and a further direction granting the "USA" a 60 day extension to serve and file a Notice of Appearance. Teva opposes the request for both directions, and opposes the grant of either Direction in the absence of a formal motion...In the circumstances, it is Teva's position that the Directions should not e issued and in any event, not without the process of a formal motion. received on 17-DEC-2012

Covering letter from Respondent, Teva Canada Limited dated 17-DEC-2012 concerning Doc. Nos. 13 14 placed on file on 17-DEC-2012

Solicitor's certificate of service on behalf of Bryan Norrie confirming service of doc. 13 Notice of Appearance upon all parties by telecopier on 17-DEC-2012 filed on 17-DEC-2012

Notice of appearance on behalf of Respondent, Teva Canada Limited filed on 17-DEC-2012

Covering letter from the Respondent, Teva Canada Limited dated 17-DEC-2012 concerning R's Motion Record and Book of Authorities - placed on file on 17-DEC-2012

Book of Authorities consisting of 1 volume(s) on behalf of the Respondent, Teva Canada Limited received on 17-DEC-2012

Motion Record containing the following original document(s): 9 10 11 Number of copies received: 3 on behalf of the Respondent, Teva Canada Limited, filed on 17-DEC-2012 with proof of service on the Applicant and Respondent on 17-DEC-2012

Written Representations contained within a Motion Record on behalf of the Respondent, Teva Canada Limited, concerning Motion Doc. No. 9 filed on 17-DEC-2012

Affidavit of Martin Brandsma sworn on 05-DEC-2012 contained within a Motion Record on behalf of the Respondent, Teva Canada Limited in support of Motion Doc. No. 9 with Exhibits "A" filed on 17-DEC-2012

Notice of Motion contained within a Motion Record on behalf of the Respondent, Teva Canada Limited returnable (but no hearing date indicated at this time) for an Order striking the respondent, Millennium Pharmaceuticals, Inc. from this application; an Order amending the style of cause in this application to remove the respondent Millennium Pharmaceuticals, Inc.; and other relief filed on 17-DEC-2012

Affidavit of service of Dave Newell sworn on 11-DEC-2012 on behalf of Applicant confirming service of Doc.1 upon Teva Cda. Ltd. by personal service on 07-DEC-2012 filed on 17-DEC-2012

Affidavit of service of Dave Newell sworn on 11-DEC-2012 on behalf of Applicant confirming service of Doc.1 upon the Minister of Health by personal service on 17-DEC-2012 filed on 17-DEC-2012

Affidavit of service of Cindy Sue Potter sworn on 14-DEC-2012 on behalf of Applicant confirming service of Doc.1 upon the Respondent Licensee and Sub-Licensor Millenium Pharmaceuticals by personal service on 14-DEC-2012 filed on 17-DEC-2012

Letter from Applicant dated 17-DEC-2012 enclosing the affidavits of service of the Notice of Application on the Respondents (Teva), the Minister of Health and the Respondent-Licensee and Sub-Licensor, Millenium Pharmaceuticals Inc. received on 17-DEC-2012

Letter from Applicant dated 14-DEC-2012 seeking a Direction granting an extension of time pursuant to Rule 8 and 304 for the Applicant to serve the United States of America represented by the Secretary, Department of Health and Human Sevices within 5 days of the issuance of this Direction. We further seek a Direction granting and extension of time pursuant to Rule 8 and 305 for the United States of America to serve and file a Notice of Appearance within 60 days of service of the Notice of Application...ç received on 14-DEC-2012

Affidavit of service of JAMES ADENEY sworn on 13-DEC-2012 on behalf of RESPONDENT, THE MINISTER OF HEALTH confirming service of NOTICE OF APPEARANCE upon Applicant by telecopier on 12-DEC-2012 confirming service NOTICE OF APPEARANCE upon RESPONDENT, TEVA CANADA LTD by telecopier on 12-DEC-2012 confirming service NOTICE OF APPEARANCE upon MILLENNIUM PHARMACEUTICALS INC. by telecopier on 12-DEC-2012 confirming service NOTICE OF APPEARANCE upon RESPONDENT PATENTEE,UNITED STATES OF AMERICA REP BY SECRETARY,DEPT OF HEALTH AND HUMAN SERVICES by FEDEX on 12-DEC-2012 with Exhibits A B filed on 13-DEC-2012

Notice of appearance on behalf of Respondent filed on 13-DEC-2012

Acknowledgment of Receipt received from all parties (by fax) with respect to doc 3 placed on file on 12-DEC-2012

Order dated 12-DEC-2012 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Motion ex proprio motu Result: IT IS ORDERED pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter. Filed on 12-DEC-2012 copies sent to parties entered in J. & O. Book, volume 1177 page(s) 393 - 394 Interlocutory Decision

Service copy of Doc. No. 1 with proof of service upon Deputy Attorney General of Canada on 10-DEC-2012 filed on 10-DEC-2012

Covering letter from Applicant dated 07-DEC-2012 concerning Doc. No. 1 placed on file on 07-DEC-2012

Notice of application and 2 copies with regard to S.55.2(4) of the Patent Act and S.6 of the Patented Medicines (NOC) Reg. filed on 07-DEC-2012 Certified copy(ies)/copy(ies) transmitted to Deputy Attorney General of Canada Tariff fee of $50.00 received: yes